Month: July 2022

VANCOUVER, British Columbia, June 30, 2022 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce the voting results of its 2022 annual general meeting (“AGM”) of shareholders that was held today as a virtual event. All of the resolutions proposed at the meeting were duly passed. A total of 148,725,971 common shares, representing 65.57% of the Company’s issued and outstanding common shares as at the record date were voted. All of the Company’s nine director nominees were elected and detailed results of the vote for directors are shown below:Name of Nominee Votes For Votes WithheldNumber % Number %R. Stuart (Tookie) Angus 134,516,515 97.48 3,484,415 2.52 Mark Eaton 99,506,016 72.11 38,494,914 27.89 Anne E. Giardini 134,193,532 97.24 3,807,398 2.76 Saurabh Handa 134,252,680 97.28 3,748,250 2.72 Cyndi...

SHANGHAI, China, July 01, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the appointments of Aileen Wang as Chief Financial Officer and Lily Yang as Chief People Officer. These appointments further strengthen Clover’s global executive leadership team to drive its next phase of growth and operational success. Ms. Wang and Ms. Yang will also work closely with LiongHo Chua, Clover’s President of Greater China, to establish and lead a China-focused operational leadership team in advance of the anticipated launch of COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), in China and around the world. “As Clover is entering a critical phase of its growth, we are taking thoughtful...